文献速递特殊人群用药药物不良反应与药物警戒

西班牙加泰罗尼亚孕期抗抑郁药处方与依从性的真实世界数据洞察

Real-World Data Insights into Antidepressant Prescription and Adherence During Pregnancy in Catalonia (Spain).
PubMed 文献 · Drug Saf · 2025-07-09

该研究基于加泰罗尼亚SIDIAP数据库2011年1月至2020年6月数据,纳入99,605次妊娠,分析孕期抗抑郁药处方模式、依从性与持续性。结果显示14.9%妊娠有抗抑郁药处方,但仅5.8%从药房取药;孕期处方与依从性下降,产后回升,约29.2%女性产后恢复用药。

要点

  • 孕期抗抑郁药处方率14.9%,但药房取药率仅5.8%,处方与取药差距显著。
  • 孕期抗抑郁药处方与依从性下降,产后时期回升,约29.2%女性产后恢复用药。
  • 帕罗西汀处方最多,舍曲林使用随时间增加;孕期新起始治疗者持续治疗可能性更高。

核心结论

  • 孕期抗抑郁药处方与药房取药之间存在显著差距,孕期处方和依从性下降而产后回升。

研究设计与样本

  • 基于SIDIAP数据库的观察性队列药物利用研究,纳入2011年1月至2020年6月加泰罗尼亚99,605次妊娠。

主要发现

  • 99,605次妊娠中14.9%有抗抑郁药处方,但仅5.8%从药房取药。
  • 妊娠中位时长38.4周,母亲中位年龄33.5岁;焦虑是与抗抑郁药处方相关的最常见健康问题。
  • 帕罗西汀是最常处方的抗抑郁药,舍曲林使用随时间增加。
  • 约11.6%妊娠同时处方另一种抗抑郁药,29.2%女性产后恢复抗抑郁药使用。
  • 孕期新起始抗抑郁药者比已有处方者更可能持续治疗。

临床怎么用

  • 临床应关注孕期抗抑郁药处方后实际取药与依从性,识别未治疗风险并加强个性化支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Affective disorders, particularly depression, are common among women of childbearing age, and pregnancy often exacerbates symptoms. Antidepressants are often required for treatment, but adherence during pregnancy is variable. Although some studies suggest potential risks to the foetus, many cannot rule out confounding by indication. In this context, understanding real-world patterns of antidepressant prescription and adherence during pregnancy is essential to inform clinical practice and ensure adequate mental healthcare. OBJECTIVE: The aim of the present study was to characterise the use of antidepressants in a cohort of pregnant women using electronic health records. METHODS: This observational cohort drug-utilisation study assessed antidepressant prescription patterns, adherence and persistence among pregnant women using data from the SIDIAP (Information System for the Development of Research in Primary Care) database in Catalonia from January 2011 to June 2020. RESULTS: Among 99,605 pregnancies, 14.9% involved antidepressant prescriptions, but only 5.8% of these were collected from pharmacies. The median pregnancy duration was 38.4 weeks, and the median maternal age was 33.5 years. Anxiety was the most common health issue associated with an antidepressant prescription. Paroxetine was the most frequently prescribed antidepressant, although sertraline usage increased over time. Antidepressant prescriptions and adherence decreased during pregnancy, with an increase in the postpartum period. About 11.6% of pregnancies involved a concurrent prescription of another antidepressant, and 29.2% of women resumed antidepressant use after pregnancy. Women who initiated antidepressants during pregnancy were more likely to persist with treatment than those with pre-existing prescriptions. CONCLUSIONS: Our study describes antidepressant use during pregnancy in Catalonia. It is remarkable that there is a notable gap between antidepressant prescriptions and dispensations. Given the risks of untreated maternal depression, strengthening primary care with adequate resources and personalised support is essential for improving perinatal mental healthcare.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Bellas L, Camacho-Arteaga L, Giner-Soriano M, et al. Real-World Data Insights into Antidepressant Prescription and Adherence During Pregnancy in Catalonia (Spain). Drug Saf. 2025. PMID: 40632487. doi:10.1007/s40264-025-01576-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。